Chai

Chai allows anyone to detect anything, anywhere with DNA, transforming biotech into an everyday productivity tool. Chai's Real-Time PCR and qPCR instruments are as accurate as a lab test, but cost 10x less, and are easy enough for anyone to use. Chai also develops PCR Master Mixes for the detection any pathogen, bacteria, virus, allergen, gene, species, or DNA tracer on-site at the point of need.

Chai is impacting large industries such as food, agriculture, research, education, and security, while providing new solutions to combat consumer fraud, protect the environment, improve global health, and make small businesses like microbrewers more profitable.

Chai headquartered in United States, North America, operates in the Biotechnology, Life Science, Medical Device, Health Diagnostics sector. The company focuses on Biotechnology and has secured $204.8M in funding across 32 round(s). With a team of 11-50 employees, Chai is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Chai, raised $1.4M. Discover more about their projects, partnerships, and impact on our platform.